Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
110,784,314
-
Total 13F shares
-
36,858,311
-
Share change
-
+10,456,035
-
Total reported value
-
$1,037,561,470
-
Put/Call ratio
-
59%
-
Price per share
-
$28.15
-
Number of holders
-
90
-
Value change
-
+$315,174,073
-
Number of buys
-
66
-
Number of sells
-
31
Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q3 2022
As of 30 Sep 2022 Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) had 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,858,311 shares of stock of the company.
Largest 10 holders included VIKING GLOBAL INVESTORS LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, Woodline Partners LP, and MILLENNIUM MANAGEMENT LLC.
This table shows 90 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.